By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Febit today announced it is restructuring its business "as a consequence of its strategic focus on blood-based microRNA biomarker discovery."

As a result, CEO and President Cord Staehler has resigned and joined Siemens Healthcare. Hartmut Voss has joined the company as co-CEO. Jochen Kohlhaas is the other co-CEO and will continue as the company's chief financial officer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.